ANIP MarketBeat 4 days ago ANI Pharmaceuticals Targets $1B+ Sales in 2026, Pivots to Rare Disease Growth at Raymond James Conf.
ANIP Simply Wall St. 5 days ago ANI Pharmaceuticals Reshapes Portfolio With Alimera Deal And Rare Disease Push
